Search Results

  • Showing 1 - 4 results of 4
Refine Results
  1. 1

    Outcome of first-line treatment with pembrolizumab according to KRAS/TP53 mutational status for nonsquamous programmed death-ligand 1-High (≥50%) NSCLC in the German national netwo... by Bischoff, Philip (Author) , Reck, Martin (Author) , Overbeck, Tobias (Author) , Christopoulos, Petros (Author) , Röper, Julia (Author) , Janning, Melanie (Author) , Stenzinger, Albrecht (Author) , Griesinger, Frank (Author) , Thomas, Michael (Author) ,


    Get full text
    Article (Journal) Online Resource
  2. 2

    Rationale and design of the phase II ANTELOPE study of atezolizumab, carboplatin and nab-Paclitaxel vs. pembrolizumab, platinum and pemetrexed in TTF-1 negative, metastatic lung ad... by Frost, Nikolaj (Author) , Bleckmann, Annalen (Author) , Griesinger, Frank (Author) , Grohé, Christian (Author) , Janning, Melanie (Author) , Kollmeier, Jens (Author) , Reinmuth, Niels (Author) , Sebastian, Martin (Author) , Thomas, Michael (Author) , Reck, Martin (Author) ,


    Get full text
    Article (Journal) Online Resource
  3. 3

    Predictive value of DNA methylation patterns in AML patients treated with an azacytidine containing induction regimen by Schmutz, Maximilian (Author) , Zucknick, Manuela (Author) , Schlenk, Richard Friedrich (Author) , Mertens, Daniel (Author) , Benner, Axel (Author) , Weichenhan, Dieter (Author) , Mücke, Oliver (Author) , Döhner, Konstanze (Author) , Plass, Christoph (Author) , Bullinger, Lars (Author) , Claus, Rainer (Author) ,


    Get full text
    Article (Journal) Online Resource
  4. 4